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PURPOSE. Previously, immunization of rats with ocular antigens induced retinal ganglion cell
(RGC) degeneration. We investigated the effect of immunization with glial cell line-derived
neurotrophic factor (GDNF) or GDNF in combination with heat shock protein 27
(GDNFþHSP) on RGCs and other retinal cells.
METHODS. Rats were immunized with GDNF or GDNFþHSP. After 4 weeks, retinas were
stained with Brn-3a and NeuN to quantify RGCs. GFAP and vimentin staining were used to
investigate macroglia. Microglia were marked with Iba1 and ED1. Amacrine cells were labeled
with parvalbumin and ChAT. Photoreceptors were evaluated with rhodopsin and opsin
staining and bipolar cells with PKCa and recoverin. For these cell types, Western blotting was
also performed.
RESULTS. Retinas of immunized animals showed a significant loss of Brn-3aþ and NeuNþ RGCs.
No significant changes could be observed in regard to macroglia. An increase in Iba1þ
microglia was detected in both groups, but little change in regard to activated microglia. A
loss of cholinergic amacrine cells was seen in the GDNFþHSP group by immunohistochem-
istry and in both groups via Western blot analysis. AII amacrine cells, bipolar cells, and
photoreceptors were not affected.
CONCLUSIONS. Immunizations led to loss of RGCs and cholinergic amacrine cells and a strong
increase in microglial cells. Our data suggest that RGC loss is the consequence of
immunization with GDNF. Astrocyte activity and its neuroprotective effects seem to be
inhibited by GDNF immunization. We presume more complex interactions between GDNF
and HSP27 because no additive effects could be observed.
Keywords: amacrine cells, glaucoma, glial cell line-derived neurotrophic factor, heat shock
protein 27, retinal ganglion cells
There are many different possibilities for classification ofglaucoma, but it is always defined by a progressive loss of
retinal ganglion cells (RGCs) and their axons and is therefore
categorized as a neurodegenerative disease.1 Glaucoma with
normal tension constitutes approximately 30% of glaucoma
cases worldwide.2 As opposed to high-pressure glaucoma, the
normotensive type leads to irreversible blindness without
existence of elevated intraocular pressure (IOP). Glaucoma
pathogenesis is still poorly understood, which is why no
curative therapy could be found until now.
Currently, there is growing evidence for an involvement of
the immune system in the disease of glaucoma.3 Increased
levels of autoantibodies against heat shock protein 27 (HSP27)
were detected in glaucoma patients who did not have an
elevated IOP.4,5 Later, a high variance of autoantibodies against
optic nerve antigens were described in glaucoma patients with
normal tension.6,7 These changes in antibody patterns of up-
and downregulation could be observed not only systemically
but also in ocular fluids.8 HSP27 was identified as one of the
potentially important antigens in glaucoma, especially normal
tension glaucoma.9,10 In cell cultures, it was demonstrated that
antibodies applied directly against small heat shock proteins on
retinal cells resulted in apoptosis.5 Cytotoxic effects occurred
at concentrations of HSP antibodies similar to those found in
the sera of many glaucoma patients, which suggests a direct
cause rather than an epiphenomenon.9 However, these findings
could not yet confirm that RGC loss in glaucoma is a direct
result of aberrant immunity. Therefore, in vivo experiments
were necessary and an autoimmune glaucoma model was
developed. This animal model was established on the basis of
immunization models for the evaluation of other diseases (e.g.,
the experimental autoimmune encephalomyelitis model for
multiple sclerosis).11,12 In those models, animals are also
immunized systemically in order to evaluate the response of
the central nervous system.
Previously, rats were immunized with an optic nerve antigen
homogenate, which is a mixture of optic nerve antigens. This
immunization led to a loss of RGCs. There was also a
correlation between duration after immunization and the
existence of autoreactive antibodies.13 Antibody deposits in
the retina after immunization provided further evidence for an
involvement of the immune system in the disease of
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glaucoma.14 The exact pathway of cell death is still unknown
in this model, but many studies indicate that autoreactive
antibodies could play a role in the pathogenesis. The goal of
our present and future studies is to find out which particular
antigens are important in glaucoma disease progress.
In previous studies, immunization with HSP27, a purified
antigen, led to loss of RGCs.15,16 In addition to autoantibodies
to HSP27, elevated antibodies against the glial cell line-derived
neurotrophic factor (GDNF) were found in glaucoma patients
with normal tension. It is still unclear if the antibodies found in
glaucoma patients are the cause or the consequence of the
disease. In a pilot study, immunization with GDNF led to a
significant loss of RGCs and was therefore chosen for the study
(Joachim SC, unpublished data, 2014).
The purposes of the present study were to determine if
immunization with GDNF alone or GDNF in combination with
HSP27 (GDNFþHSP) would lead to a loss of RGCs and to
investigate effects on other retinal cells. We were able to reveal
a significant loss of RGCs, an increase in microglial cells and a
loss of cholinergic amacrine cells in both immunization groups.
MATERIALS AND METHODS
Animals
Male Lewis rats between 7 and 8 weeks of age (Charles River,
Sulzfeld, Germany) were kept in a constant temperature and
received food and water ad libitum. Illumination was adjusted
to a 12/12-hour dark/light cycle. Daily examinations of general
condition and welfare were performed, including observation
of ophthalmic disorders. All animals were treated according to
the ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research. The study was approved by the animal care
committee of North Rhine-Westphalia (Germany; AZ 87-
51.04.2010.A382 and AZ 23177-07; G 09-1-044).
Immunization
Rats were randomly divided in 2 immunization groups and 1
control group (Co; n ¼ 4–5 animals/group). In previous
studies, the dose of 100 lg of purified HSP27 caused retinal
ganglion cell damage.15,17 We wanted to evaluate additive
effects and therefore chose the following concentrations.
Each animal in the GDNF group received 200 lg of GDNF
(Biotrend Chemicals, LLC, Destin, FL, USA). Animals in the
GDNFþHSP group were injected with 100 lg of GDNF plus
100 lg of HSP27 (AtGen, Yatap-dong, South Korea), whereas
animals in the control group received 200 lL of a 0.9%
sodium chloride solution.15,17 Simultaneously, 3 lg of
pertussis toxin and 200 lL of Freund’s adjuvant were
administered to each animal. Solutions were given by
intraperitoneal injection.
Animals were checked daily for 1 week after immunization,
then twice a week. According to a checklist, attention was
given to coordination, possible swelling of the injection site,
behavior, respiration, healthy mouth, stable or increasing
weight, normal feces, and possible hemorrhage. Eyes were
examined for blepharospasm, ocular discharge, redness,
chemosis, and opacities of the cornea or lens. Parameters
were evaluated using a scoring system, and all rats achieved a
condition score of zero throughout the whole study, which
meant that no abnormalities were found.
Measurement of Intraocular Pressure
Intraocular pressure was measured after instillation of a topical
anesthetic (Novesine 0.4%; Omni Vision GmbH, Puchheim,
Germany), using a TonoPen XL (Medtronic, Baseweiler,
Germany).18 Measurements were performed before, then at
2, and at 4 weeks after immunization, always at the same time
of day by the same examiner.
Funduscopy
To manage funduscopy, the rats had to be generally anesthe-
tized. A mydriatic (Mydriatikum Stulln, Pharma Stulln, Ger-
many) was applied topically. A glass slide with contact medium
(Methocel 2%; Omni Vision) was carefully pressed onto the
locally anesthetized cornea. Then fundi were examined
through a binocular surgical microscope (Carl Zeiss, Jena,
Germany) in search of signs of damage at 2 and 4 weeks after
immunization.
Tissue Preparation for Retinal Cross-Sections and
Histology
Four weeks after immunization, rat eyes were enucleated and
fixed in 4% paraformaldehyde. Thereafter, one eye of each
animal (n ¼ 4–5/group) underwent a sucrose treatment, was
embedded in compound (Tissue-Tek; Fisher Scientific,
Schwerte, Germany), and stored at a temperature of 808C.
Cross-sections 10 lm thick were made with a cryostat (Fisher
Scientific) for further staining. For an overview, cross-sections
(n ¼ 5 eyes/group; 4 cross-sections/eye) were evaluated by
light microscopy (Axio Imager M1; Zeiss) after staining with
hematoxylin and eosin (H&E) and cresyl violet (Nissl) by using
standard protocols.19 Retinas of the other eye were prepared
for Western blotting.
Histology of Retinal Cell Types
In order to identify the different retinal cell types, specific
antibodies were used for immunofluorescence staining (n¼ 4–
5/group; 6 sections/animal) (Table). Briefly, sections of the
retina were blocked with a solution containing donkey and/or
goat serum and 0.1% to 0.2% Triton-X in PBS. Sections were
incubated with primary antibodies at room temperature
overnight. The next day, incubation with corresponding
secondary antibodies was performed for 1 hour. Nuclear
staining with 40,6-diamidino-2-phenylindole (DAPI; Dianova,
Hamburg, Germany; or Serva Electrophoresis, Heidelberg,
Germany) was included to facilitate orientation on the slides.
Negative controls were performed for each stain by using
secondary antibodies only.
Histologic Examination
The photographs were taken using a fluorescence microscope
(Axio Imager model M1; Zeiss). Two photos of the peripheral
and two of the central part of each section were captured for
each group. Images were transferred to Paint Shop Pro version
13 software (Corel Corp., CA, USA), and equal excerpts were
cut out. RGCs, microglia, amacrine cells, bipolar cells, and
cones were counted using ImageJ software (http://imagej.nih.
gov/ij/; provided in the public domain by the National
Institutes of Health, Bethesda, MD, USA).
Measurements and analyses of GFAP-, vimentin-, and
rhodopsin-labeled areas were evaluated using ImageJ soft-
ware, as described previously.19 Briefly, images were
transformed into grayscale. A fixed background with a rolling
ball radius of 50.0 pixels was subtracted from GFAP and
vimentin images. The percentage (%) of the labeled area was
then measured between defined thresholds (GFAP lower
threshold was 4.18; upper threshold was 66.98; vimentin
lower threshold was 9.20; upper threshold was 67.42; and
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rhodopsin lower threshold was 11.02; upper threshold was
54.51).
Western Blot Analysis
Retinas were prepared for Western blot analysis (n ¼ 3-4/
group) as previously described.20 To isolate proteins, the
frozen retinas were mechanically homogenized in 150 lL of
lysis buffer (Radioimmunoprecipitation assay buffer; Cell
Signaling Technology, Danvers, MA, USA) and a protease
inhibitor (Sigma-Aldrich Corp., St. Louis, MO, USA). Ultrasound
was then used for an accurate homogenization. Samples were
placed on ice for 50 minutes, followed by centrifugation at 48C
at 13,200 rpm for 30 minutes to reduce the last solid particles.
The protein concentration was measured using a commercial
bicinchoninic acid assay (BCA protein assay kit; Pierce
Technology, Holmdel, NJ, USA). We applied 20 lg per lane to
a 12% bis-Tris gel (NuPAGE; Invitrogen, Carlsbad, CA, USA) for
electrophoresis and blotted afterward, using a transfer buffer
(NuPAGE) for 60 minutes at 200 V. Nitrocellulose membranes
were blocked in a solution of 5% milk powder/PBS/0.05%
Tween-20. Primary antibodies were applied and incubated
overnight, followed by secondary antibodies for 60 minutes
(Table). An Odyssey infrared imager system 2.1 (LI-COR
Biosciences, Lincoln, NE, USA) recorded and analyzed the
stained protein bands. Two measurements of each animal were
used for statistical analysis.
Statistics
Cell counts, evaluated area fractions, and Western blot data
were compared by ANOVA followed by Dunnett post hoc test.
IOP was analyzed using ANOVA, followed by Tukey post hoc
test. Data are mean 6 SEM. Statistical analysis was performed
by Statistica version 12 software (StatSoft, Tulsa, OK, USA).
RESULTS
In Vivo Parameters
Animals were in a good condition during the whole study. Daily
examination of the rats showed no abnormal findings. Special
attention was given to coordination, behavior, movement,
orientation, and signs of paralysis. Eyes showed no signs of
inflammation or discomfort.
Time Course of Intraocular Pressure and
Funduscopy
At baseline, no differences in IOP could be noted in all
immunization groups compared to control (Co: 11.81 6
0.45 mm Hg; GDNF: 11.81 6 0.34 mm Hg; GDNFþHSP:
10.93 6 0.15 mm Hg; P > 0.05). Two weeks after
immunization, IOP stayed in a normal range in all groups
(Co: 12.02 6 0.25 mm Hg; GDNF: 11.76 6 0.3 mm Hg;
GDNFþHSP: 11.2 6 0.18 mm Hg; P > 0.05). Also, after 4
weeks, we could not find any IOP elevation by comparison
between the immunized groups and control (Co: 11.45 6
0.23 mm Hg; GDNF: 11.66 6 0.15 mm Hg; GDNFþHSP:
11.39 6 0.24 mm Hg; P > 0.05) (Fig. 1B).
Funduscopy revealed no abnormalities of the optic nerve
head or of retinal vasculature in the control group or in the
immunization groups after 2 and 4 weeks (Fig. 1A).
Retinal Histology
Retinal cross-sections were stained with H&E (Fig. 2A) and
cresyl violet (Fig. 2B) to get an overview of changes in
structure. Retinal layers were always well defined, and no
infiltrates or signs of inflammation could be seen. In
comparison, the control retinas and those of the immunization
groups showed no difference in histology.
TABLE. Antibodies Used for Histology and Western Blot
Primary Antibody Secondary Antibody
Antibody Company Application Dilution Antibody Company Application Dilution
b-III tubulin R&D Systems Western blot 1:1000 Donkey anti-mouse Alexa Fluor 680 Invitrogen Western blot 1:5000
Brn-3a Santa Cruz Histology 1:100 Donkey anti-goat Alexa Fluor 488 Dianova Histology 1:400
ChAT Millipore Histology 1:100 Goat anti-mouse Alexa Fluor 488 Invitrogen Histology 1:500
Western blot 1:500 Donkey anti-mouse Alexa Fluor 680 Invitrogen Western blot 1:5000
ED1 Millipore Histology 1:250 Goat anti-mouse Alexa Fluor 488 Invitrogen Histology 1:500
GFAP-A488 Millipore Histology 1:1200
GFAP Millipore Western blot 1:3000 Donkey anti-chicken IRDye 680RD LI-COR Western blot 1:20000
Iba1 Wako Histology 1:400 Goat anti-rabbit Cy3 Linaris Histology 1:500
NeuN Millipore Histology 1:500 Donkey anti-chicken Cy3 Millipore Histology 1:400
Opsin Millipore Histology 1:200 Donkey anti-rabbit Alexa Fluor 555 Invitrogen Histology 1:500
Parvalbumin Swant Histology 1:100 Donkey anti-goat Alexa Fluor 488 Dianova Histology 1:400
PKCa Santa Cruz
Biotechnology
Histology 1:500 Goat anti-mouse Alexa Fluor 488 Invitrogen Histology 1:500
Recoverin Millipore Histology 1:1000 Donkey anti-rabbit Alexa Fluor 555 Invitrogen Histology 1:400
Western blot 1:2000 Donkey anti-rabbit Alexa Fluor 680 Invitrogen Western blot 1:5000
Rhodopsin Abcam Histology 1:400 Goat anti-mouse Alexa Fluor 488 Invitrogen Histology 1:500
Western blot 1:1000 Donkey anti-mouse Alexa Fluor 680 Invitrogen Western blot 1:5000
TSPO Abcam Western blot 1:100 Donkey anti-rabbit Alexa Fluor 680 Invitrogen Western blot 1:5000
Vimentin Sigma-Aldrich Histology 1:500 Goat anti-mouse Alexa Fluor 555 Invitrogen Histology 1:400
Western blot 1:500 Goat anti-mouse IgM IRDye 680RD LI-COR Western blot 1:20000
b-actin Sigma-Aldrich Western blot 1:6000 Donkey anti-mouse DL800 LI-COR Western blot 1:20000
b-actin Cell Signaling Western blot 1:6000 Donkey anti-rabbit DL800 Thermo Fisher
Scientifc
Western blot 1:5000
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Retinal Ganglion Cell Loss
To improve reliability of cell counts, two different markers for
RGC evaluation were used. Brn-3a is a specific marker for
RGCs, whereas NeuN stains all neuronal cells. Most of the
labeled cells displayed colocalization of the stains (Fig. 3A).
The small amount of solely NeuN-stained cells were likely to be
dislocated amacrine cells.21 Retinas of immunized animals
showed a significant loss of Brn-3a-stained RGCs (Co: 29.91 6
2.14 cells/mm; GDNF: 20.01 6 2.77 cells/mm; P ¼ 0.01;
GDNFþHSP27: 21.35 6 0.21 cells/mm; P ¼ 0.04) (Fig. 3C).
These results were confirmed by Western blot analysis using an
anti-b-III tubulin antibody (Fig. 3B), another marker for RGCs.22
The b-III tubulin levels of the GDNF group (Co: 50.17 6 10.8
units; GDNF: 11.95 6 5.1 units; P ¼ 0.01) and of the
GDNFþHSP group (12.4 6 2.8 units; P¼ 0.02) (Fig. 3D) were
decreased compared to those of controls.
Also, the number of NeuN-labeled cells was significantly
reduced in both groups compared to controls (Co: 30.08 6 1.4
cells/mm; GDNF: 22.5 6 2.69 cells/mm; P ¼ 0.03;
GDNFþHSP27: 22.29 6 0.76 cells/mm; P ¼ 0.03) (Fig. 3E).
No Macroglial Alteration
Gliosis seems to be an epiphenomenon of neuronal damage.
Therefore, astrocytes and Mu¨ller cells were analyzed using
GFAP or vimentin area analysis (Fig. 4A). In the GDNF group
(10.35 6 1.53 area [%]/section), the GFAPþ area was slightly
increased compared to that in the control group (6.56 6 0.92
area [%]/section; P ¼ 0.1) (Fig. 4C). In the GDNFþHSP group
(7.196 1.42 area [%]/section), no increase in the GFAP stained
area was noted (P ¼ 0.9) (Fig. 4C).
GFAP levels in retinas were also investigated by using
Western blot analysis (Fig. 4B). The GFAP protein level,
measured at 55 kDa, revealed no changes in the GDNF group
(Co: 14.33 6 2.48 units; GDNF: 15.75 6 2.75 units; P ¼ 0.9)
(Fig. 4D). Also, no alterations were noted in the GDNFþHSP
group (17.89 6 3.32 units; P ¼ 0.6) (Fig. 4D).
The vimentinþ areas showed no alterations in the GDNF
group (Co: 12.93 6 1.91 area [%]/section; GDNF: 15.12 6
1.59 area [%]/section; P ¼ 0.5) or in the GDNFþHSP group
(14.21 6 2.20 area [%]/section; P¼ 0.8) (Fig. 4E). For vimentin
with a molecular weight of 58 kDa, no increase in the protein
level in the GDNF group (Co: 8.27 6 2.9 units; GDNF: 8.19 6
1.74 units; P¼ 0.99) or in the GDNFþHSP group was observed
(4.58 6 0.11 units; P¼ 0.5) by Western blot analysis (Fig. 4F).
Increased Numbers of Resting Microglia Cells
The whole population of microglia was labeled with Iba1. To
identify activated microglia, the sections were also stained with
ED1 (Fig. 5A). Additionally, activated microglia were quantified
using translocator protein (TSPO) in Western blot analysis.
Figure 5A shows cell bodies and dendrites of microglia
stained (red) with Iba1. Colocalization with ED1 (green), as seen
in the merged picture, identifies the cell as active microglia.
Significantly more Iba1þ cells were revealed in the GDNF group
(Co: 5.81 6 0.82 cells/mm; GDNF: 21.16 6 2.42 cells/mm; P <
0.001). Also, a significantly higher number of Iba1þ cells was
noted in the GDNFþHSP group (18.31 6 0.78 cells/mm; P <
0.001) (Fig. 5E). Evaluation of the activation marker ED1 in
combination with Iba1 showed no significant differences
FIGURE 1. (A) Funduscopy photos of retinas of control and immunized
animals at different points in time. No pathologic changes or signs of
inflammation could be seen. (B) Mean IOP levels at baseline and two as
well as four weeks after immunization. IOP remained in the normal
range throughout the whole study and showed no difference between
the immunization groups compared to control (P > 0.05). Values
represent mean 6 SEM; n¼ 5/group.
FIGURE 2. (A) Staining with H&E visualizes the retinal layers. Retinas
of the immunization groups showed no inflammation or damage of
retinal layers; morphology was comparable to that of controls. (B)
Cresyl violet staining reveals normal organization of retinal layers in all
groups. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner
nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; OS,
outer segment. Scale bar: 40 lm.
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FIGURE 3. (A) Exemplary cross-sections of retina stained with Brn-3a (green), NeuN (red), and DAPI (blue) to quantify RGCs. Arrows indicate
colocalization of Brn-3a- and NeuN-stained cells. (B) Western blot bands for b-III tubulin and b-actin. A less intense b-III tubulin staining for
immunization groups can be observed. (C) Retinas of both of the immunization groups showed a significant loss of RGCs when labeled with Brn-3a
(GDNF: P ¼ 0.01; GDNFþHSP: P ¼ 0.04). (D) Western blot analysis revealed a significant decrease in b-III tubulin staining in both of the
immunization groups (GDNF: P¼ 0.01; GDNFþHSP: P¼ 0.02). (E) A significant loss of RGCs was also detected using NeuN staining (GDNF: P¼
0.03; GDNFþHSP: P¼ 0.03). Values are mean 6 SEM. GCL, ganglion cell layer; IPL, inner plexiform layer; IF, n¼ 4 to 5/group; Western blot (WB), n
¼ 3 to 4/group. Scale bar: 20 lm.
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between GDNF animals (10.00 6 4.05 cells/mm) and controls
(1.68 6 0.26 cells/mm) (Fig. 5C). No changes were observed in
the GDNFþHSP group (5.16 6 1.07 cells/mm; P¼ 0.6).
Western blots were stained with TSPO, which is upregu-
lated in microglia during neuroinflammation.23–26 Western blot
bands were measured at a molecular weight of 18 kDa (Fig.
5B). In accordance with ED1 results, no differences could be
detected in the GDNF group (0.83 6 0.28 units; P¼ 0.71) and
in the GDNFþHSP group (0.87 6 0.08 units; P ¼ 0.67)
compared to the control (0.65 6 0.11 units) (Fig. 5D).
FIGURE 4. (A) Retinal sections were stained with GFAP (green), vimentin (red), and DAPI (blue) to detect possible alterations in macroglia. GFAP is
sensitive mainly to astrocytes, whereas vimentin is expressed mostly in Mu¨ller cells. (B) Representative Western blot images of GFAP, vimentin, and
corresponding b-actin bands from retinas of control and immunized animals. (C) No significant changes could be observed in regard to GFAP area in
the GDNF (P¼ 0.1) or GDNFþHSP group (P¼ 0.9). (D) Western blot analysis results showed no differences between GFAP staining in the GDNF
group (P¼ 0.9) and that in the GDNFþHSP group (P¼ 0.6) compared to staining in controls. (E) Vimentin staining revealed no alterations in either
of the immunization groups (P > 0.05). (F) No differences were observed between Western blot analysis of vimentin in the GDNF group (P¼ 0.99)
and that in the GDNFþHSP group (P¼ 0.5). Values are mean 6 SEM. GCL, ganglion cell layer; IPL, inner plexiform layer; IF, n¼ 4 to 5/group; WB. n
¼ 3 to 4/group. Scale bar: 20 lm.
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FIGURE 5. (A) Active microglia were stained with ED1 (green) and the whole population of microglial cells with Iba1 (red). Merged pictures show
colocalization of both cells, which definitely identifies an active microglial cell. (B) Western blot pictures of TSPO and b-actin staining show exemplary
bandsofcontrol and immunizedanimals. (C)NodifferenceswereobservedbetweenED1stainingof the immunizationgroups and thatof control (GDNF:P
¼0.07;GDNFþHSP:P¼0.7). (D) In accordance to immunohistochemistry,Westernblot analysis did not showany changes inTSPOsignal intensity (GDNF:
P¼0.7; GDNFþHSP: P¼0.7). (E) Iba1þ cells were significantly increased in both of the immunization groups (P< 0.001). Values are mean6 SEM. GCL,
ganglion cell layer; INL, inner nuclear layer; IPL, inner plexiform layer; IF, n¼4 to 5/group; Western blot (WB), n¼3 to 4/group. Scale bar: 20 lm.
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Cell Loss of Particular Amacrine Cells
The cholinergic amacrine cells were labeled with a ChAT
antibody, whereas the AII amacrine cells were marked with a
parvalbumin antibody (Fig. 6A). Retinas of GDNF rats showed
constant numbers of cholinergic amacrine cells (1.53 6 0.55
cells/mm; P ¼ 0.5) compared to controls (2.35 6 0.68 cells/
mm) (Fig. 6C). However, counting of the cell bodies in the
GDNFþHSP group revealed a significant loss of cholinergic
amacrine cells (0.08 6 0.08 cells/mm; P ¼ 0.03) (Fig. 6C).
We performed additional Western blot analysis with ChAT
staining and measurement of bands at 68 kDa (Fig. 6B). Signal
intensity was significantly decreased in both immunization
groups (GDNF: 2.39 6 0.41 units; P¼ 0.001; GDNFþHSP: 2.54
6 0.74 units; P ¼ 0.002) compared to controls (8.11 6 1.04
units) (Fig. 6D).
AII amacrine cells were not affected in the GDNF group
(Co: 33.24 6 3.58 cells/mm; GDNF: 34.31 6 2.45 cells/mm; P
¼ 0.9) and in the GDNFþHSP group (27.91 6 3.45 cells/mm; P
¼ 0.4) (Fig. 6E).
In summary, no difference in AII amacrine cells was
observed but a loss of cholinergic amacrine cells was noted
in both immunization groups.
No Effects on Bipolar Cells
In order to identify different bipolar cells, retinal cross-sections
were stained with PKCa and recoverin. Rod bipolar cells
FIGURE 6. (A) Staining of cholinergic amacrine cells with ChAT (red) and staining of AII amacrine cells with parvalbumin (green). Cell nuclei were
labeled with DAPI (blue). A ChATþ-stained cell body is shown in the control group (arrow). (B) Exemplary Western blot images of ChATand b-actin. (C)
ChAT-stained cell bodies were counted. No differences were observed in the GDNF group (P¼0.5), but a significant losswas detected in the GDNFþHSP
group (P¼ 0.03). (D) A significant decrease in ChAT signal intensity was evaluated by Western blot analysis in the GDNF (P¼ 0.001) and GDNFþHSP
groups (P¼ 0.002). (E) No changes in AII amacrine cells were revealed with parvalbumin staining (GDNF: P¼ 0.96; GDNFþHSP: P¼ 0.44). Values are
mean 6 SEM. IPL, inner plexiform layer; INL, inner nuclear layer; IF, n¼ 4 to 5/group; Western blot (WB), n¼ 3 to 4/group. Scale bar: 20 lm.
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(PKCa [green]) and cone bipolar cells (recoverin [red]) are
located in the inner nuclear layer (Fig. 7A).
Staining with recoverin revealed no alterations in the
GDNF group (Co: 46.67 6 3.67 cells/mm; GDNF: 37.38 6
2.67 cells/mm; P ¼ 0.1) and in the GDNFþHSP group (42.49
6 3.62 cells/mm; P ¼ 0.6) (Fig. 7C). Western blot analysis
was performed for recoverin staining with bands at 26 kDa
and could detect no changes between immunization groups
FIGURE 7. (A) Cone bipolar cells were evaluated using recoverin staining (red) and rod bipolar cells by using PKCa staining (green). (B)
Representative pictures show Western blot lanes stained with recoverin and b-actin. (C) Recoverinþ cells were not altered in either of the
immunization groups compared to control (GDNF: P¼ 0.1; GDNFþHSP: P¼ 0.6). (D) Recoverin-stained Western blots did not detect differences
between the groups (GDNF: P ¼ 0.5; GDNFþHSP: P ¼ 0.3). (E) Evaluation of rod bipolar cells with PKCa staining could detect no differences
between immunization groups and control (GDNF: P¼ 0.8; GDNFþHSP: P¼ 0.4). Values are mean 6 SEM. IPL, inner plexiform layer; INL, inner
nuclear layer; OPL, outer plexiform layer; IF, n ¼ 4 to 5/group; Western blot (WB), n¼ 3 to 4/group. Scale bar: 20 lm.
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(GDNF: 13.99 6 0.67 units; P ¼ 0.5; GDNFþHSP: 12.88 6
1.84 units; P ¼ 0.3) and controls (16.17 6 1.76 units) (Fig.
7D). In regard to PKCa, no changes were noted in the GDNF
group (94.05 6 9.61 cells/mm; P ¼ 0.08) compared to
controls (87.83 6 6.37 cells/mm) (Fig. 7E). Also, no
differences were observed in GDNFþHSP animals (101.73 6
7.07 cells/mm; P ¼ 0.4).
No Alteration of Photoreceptors
Rhodopsin staining was used to evaluate changes in rods (Fig.
8A). The size of the stained area was measured. No differences
could be detected between the control and the GDNF group
(Co: 6.90 6 0.47 area [%]/section; GDNF: 5.77 6 1.07 area
[%]/section; P¼ 0.6). Also in the GDNFþHSP group, rods were
not altered compared to those of controls (GDNFþHSP: 6.91 6
1.48 area [%]/section; P¼ 0.99) (Fig. 8C). Rhodopsin was also
evaluated by Western blot analysis with a band at 39 kDa (Fig.
8B). We could detect a constant signal intensity in the GDNF
group (239.12 6 39.93 units; P ¼ 0.9) and in the GDNFþHSP
group (201.07 6 38.3 units; P ¼ 0.9) compared to controls
(223.15 6 28.52 units) (Fig. 8D).
Mostly L-cones are located in the rat retina.27 Therefore, we
labeled this cell type with opsin (Fig. 8A). Opsinþ cells were
counted, and the number was comparable in all groups (Co:
42.38 6 2.81 cells/mm; GDNF: 39.35 6 4.95 cells/mm; P ¼
0.8; GDNFþHSP: 37.58 6 5.14 cells/mm; P ¼ 0.7) (Fig. 8E).
Therefore, we asserted that photoreceptors were not affected
by the immunization.
DISCUSSION
The involvement of the immune system in the disease of
glaucoma was previously evaluated in different studies.
Antibodies against ocular antigens can be detected in
glaucoma patients, but it is still unclear if these antibodies
are the cause or consequence of this disease.7,8 In an
autoimmune glaucoma animal model, glaucoma-related
retinal changes could be demonstrated after immunization
with ocular antigens.15 In accordance with those studies, we
now could show that immunization with two purified
antigens led to neuronal cell loss in the retina. To our
knowledge, this is the first study to demonstrate a loss of
RGCs and other changes in the rat retina after immunization
with GDNF and GDNFþHSP.
Heat shock proteins are small proteins which act intracel-
lularly as chaperones. They are upregulated in situations of
stress (e.g., glaucoma) and have cytoprotective effects. Tezel et
al.5 noted that autoantibodies to HSP27 were increased most
prominently in glaucoma patients without an elevated IOP and
that HSP27 was identified as one of the important antigens in
normal tension glaucoma patients.10 It was further demon-
strated that exogenously applied HSP27 antibody binds to actin
filaments and can lead to a cellular breakdown.28 In previous
studies, immunization with HSP27 alone resulted in loss of
RGCs15,17 and was hypothesized to act as an antigenic stimulus
after immunization.15
To find out more about specific antigens that might
contribute to glaucomatous damage, we examined possible
effects of another antigen, which might be of interest,
namely GNDF. GDNF is a distant member of the TGF-b
superfamily and a potent survival factor for dopamine
neurons. It acts neuroprotectively in animal models of
Parkinson disease, which led to the assumption it could be
a useful drug for the treatment of neurodegenerative
diseases.29 In vitro studies have recently demonstrated a
neuroprotective effect of GDNF on the porcine retina.30 In
contrast, in a pilot study, GDNF led to loss of RGCs after
immunization and was therefore also chosen for this study.
Here, we also combined GDNF with HSP27 to reveal
whether this combination led to additional cell loss or not.
Retinal Ganglion Cells Loss
Immunization with GDNF led to loss of RGCs, although it is
known to be neuroprotective. We also proposed an antigenic
reaction to GDNF immunization, as there is no neuroprotec-
tion but actually a damage of neuronal cells after immunization.
Interestingly, immunization with the combination of GDNF and
HSP27 did not lead to a greater loss of RGCs. One would
suspect an additive loss of neuronal cells after the immuniza-
tion with the combination of GDNF and HSP27, as immuniza-
tion with HSP27 alone leads to RGC loss.15,17 In another study
conducted by our group, we found a comparable result after
immunization with a combination of HSP27 and the S100B
protein.16 Here, immunization with the combination did not
lead to a greater loss of RGCs than the immunization with
S100B alone. The reason for these results could be explained
by the duration of the study after immunization. The cell loss in
a study with HSP27 alone did not occur before five weeks after
immunization.17 Possibly, the cell loss observed in the
GDNFþHSP group was triggered only by GDNF 4 weeks after
immunization.
Glia Cells
Glial cells are an important factor for neuronal health.
Astrocytes and Mu¨ller cells are macroglial cells and control
homeostasis. They eliminate neuronal waste, such as carbon
dioxide and ammonia, and protect neurons by recycling
neurotransmitters in healthy tissues,31 but there are still
discussions about whether gliosis acts as a neuroprotectant
or a neurodestructant during neurodegeneration.32 Mu¨ller
cells form radial columns throughout the retina, whereas
astrocytes are mostly located in the nerve fiber layer.31 We
evaluated astrocytes via GFAP and Mu¨ller cells via vimentin
staining. Previous studies showed an increased expression of
GFAP after neuronal damage, as seen in the disease of
glaucoma.32 Only a tendency of this effect could be noted in
our study in the GDNF group. No gliosis was noted in the
GDNFþHSP group. In a study by Wax et al.,15 an increase of
GFAP expression was observed after immunization with
HSP27 alone. In a previous study by our group, using S100B
and HSP27, we also noted gliosis in the combination
group.16 Therefore, one could have presumed a stronger
reaction of astrocytes. On the contrary, a study of nerve
regeneration after spinal cord injury showed a decreased
production of GFAP and reduced hypertrophy of astrocytes
after GDNF treatment in combination with Schwann cells.33
Although GDNF alone led to a tendency of increase in GFAP
staining, no increase was seen when it was combined with
HSP27. Therefore, we presume that there are interactions
between GDNF and HSP27.
Mu¨ller cells are upregulated in situations of retinal disease
like retinal detachment or high-pressure glaucoma.34,35 They
can be detected by vimentin staining,36 but in situations of
neurodegeneration, the expression of GFAP is also increased in
these cells. We could not detect any differences in regard to
vimentin. The results are similar to previous results of our
group, where we observed only increased GFAP expression
and no vimentin increase after immunization with S100B and
HSP27.16
Microglia are the resident macrophages of the retina.
These cells show immune activity, and they are important for
the development and maintenance of the neuronal network
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and for tissue homeostasis.37 After retinal injury, they can be
stimulated to undertake phagocytosis of degenerating retinal
neurons.31 They can be in a resting (inactive) or active
state.37 An increase in microglia was detected in different
models of glaucoma, for example, after induced hyperten-
sion38 or optic nerve damage.39 Also, an increase in activated
microglia could be evaluated in the autoimmune glaucoma
model 14 days after immunization with optic nerve antigen
FIGURE 8. (A) Rhodopsin (rods, green) and opsin (L-cones, red) staining of retinal sections was performed to evaluate photoreceptors. (B) Exemplary
Western blot images after rhodopsin and b-actin staining. (C) No changes were detected after rhodopsin staining for immunohistochemistry (GDNF: P
¼0.6; GDNFþHSP: P¼0.99). (D) Western blot results of rhodopsin could reveal no differences between immunization groups and control (GDNF: P¼
0.9; GDNFþHSP: 0.9). (E) No differences could be seen with regard to opsin staining in the control group (GDNF: P¼0.8; GDNFþHSP: P¼0.7). Values
mean 6 SEM. ONL, outer nuclear layer; OS, outer segment; IF, n¼ 4 to 5/group; WB, n¼ 3 to 4/group. Scale bar: 20 lm.
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and S100.20 In accordance with this, we could detect a
significant increase of Iba1þ microglia. However, activated
microglia showed only a tendency of increase in the GDNF
group. Strong microglial reactions have been found in early
stages of retinal damage20 and decreased between 3 and 12
weeks.39 Our results after 4 weeks will therefore likely
represent the decreasing phase.
Decline of Amacrine Cells
Amacrine cells are interneurons at the second synaptic level,
yet there are currently no data for whether immunization
with GDNF or HSP27 affects this cell type. Amacrine cells
are a highly diverse class of retinal neurons. Those that use
glycine as a neurotransmitter are small-field amacrine cells.
The most common type of small-field amacrine cells in the
mammalian retina is the AII amacrine cell. It connects rod
and cone photoreceptor pathways.40,41 The cholinergic
amacrine cells, on the other hand, are known to use
acetylcholine (ACh) as the neurotransmitter. They can be
differentiated into two types. One is the ACh-a type, whose
cell bodies are located in the inner nuclear layer. The cell
bodies of the second type, called ACh-b, are displaced to the
ganglion cell layer.21,42 Here, we focused on the ACh-a type
by labeling them with an anti-ChAT antibody. A loss of
cholinergic amacrine cells was found only in the GDNFþHSP
group by immunohistochemistry but in both immunization
groups by Western blot analysis. Differences between results
can be explained with the use of proteins of the whole
retina for a Western blot and the evaluation of particular
retinal layers in immunohistochemistry. Cholinergic ama-
crine cells are sending their long dendrites into the inner
plexiform layer, seen as stratification. Loss of stratification is
not included in the statistics when the cell bodies are
counted. Therefore, the Western blot analysis seems to be
more sensible with this cell type. The environment in
surrounding tissues will change after a loss of RGCs, and
cholinergic amacrine cells can be affected, as was demon-
strated in a mouse model of optic nerve injury.43 Based on
our results in regard to the missing macroglia gliosis, we
presume that the cholinergic amacrine cells were more
vulnerable and therefore a destructive effect of GDNF
immunization is apparent at this point in time.
The AII amacrine cells were not affected through the
immunization. As already mentioned, AII amacrine cells are
connected with many dopamine amacrine cells.44 Since GDNF
is known to act neuroprotectively on dopamine neurons,29
there could be a positive effect on the neighboring AII
amacrine cells.
No Effect on Bipolar Cells
Cell bodies of bipolar cells are also located in the inner
nuclear layer and are sending their dendrites into the outer
plexiform layer. They are connected either with rods or
cones.45 We used PKCa to label the rod bipolar cells and
recoverin for cone bipolar cells.46 Neither of these cell types
was affected at 4 weeks after immunization. In an ocular
hypertension model, a loss of dendritic processes of rod
bipolar cells was documented after 3 weeks.47 In another
study, a significant reduction of bipolar cells was not detected
before 5 weeks after elevation of IOP.36 A study by Park et
al.48 revealed a decrease in synapses after loss of RGCs due to
ocular hypertension and it would be of interest if the same
effect occurs IOP-independently after ganglion cells loss due
to immunization at later points in time.
No Damage of Photoreceptors
Cells of the outer retina, the photoreceptors, remained
unaffected after immunization. In different animal models of
hypertension glaucoma, a loss of photoreceptors was
noted.49,50 Until now, there have not been many studies of
photoreceptors in normal tension glaucoma models, but the
retinal layers were well organized in a previous study of the
autoimmune glaucoma model.16 Therefore, we would not
have presumed changes in photoreceptors in this model at
this stage of degeneration. These results indicate various
mechanisms in glaucoma pathology. It is important to
evaluate high-pressure as well as normal tension glaucoma
in adequate animal models.
CONCLUSIONS
In summary, our findings demonstrated for the first time that
immunizing rats with GDNF alone or in combination with
HSP27 led to a significant loss of RGCs and an increase in
inactive microglia after 4 weeks. Additionally, both groups
showed a loss of cholinergic amacrine cells. In the GDNF and
the GDNFþHSP group we detected only a slight or no gliosis.
Activation of astrocytes, which was seen after immunization
with HSP alone, seems to be inhibited by GDNF. This is the
reason why we presume complex processes between GDNF
and HSP27. The immunization with GDNF is the cause for
retinal damage in our study.
It will be the task of following studies to evaluate the retina
at a later point in time after immunization. Furthermore,
varying concentrations of antigens could reveal concentration
dependent neuroprotective or neurodestructive mechanisms.
This way a further understanding of the effects of immuniza-
tion with GDNF and GDNFþHSP and the interaction between
the two antigens can be reached. The aim of many current
glaucoma model studies is to find a method for neuroprotec-
tion. Hence, it is very important to clarify if a substance or a
combination acts as a neuroprotective or neurodestructive
agent.
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